![]()
展鹏
-
教授
博士生导师
硕士生导师
- 性别：男
- 毕业院校：山东大学
- 学历：博士研究生毕业
- 学位：医学博士学位
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2010-07-26
- 办公地点：山东大学国家大学生科技园（二环南路）3号楼14层1435房间
- 联系方式：13793130595
- 电子邮箱：zhanpeng1982@sdu.edu.cn
访问量：
-
[261]
展鹏 and 刘新泳.
Recent applications of click chemistry in drug discovery.
Expert Opin Drug Discov,
2019.
-
[262]
展鹏 and 刘新泳.
Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 .
Future Med Chem,
2019.
-
[263]
刘新泳.
Molecular design opportunities presented by solvent-exposed regions of target proteins.
Med Res Rev.,
2019.
-
[264]
展鹏 and 刘新泳.
Strategies for the Discovery of Target-Specifific or Isoform-Selective Modulators.
Journal of Medicinal Chemistry,
2015.
-
[265]
展鹏 and 刘新泳.
Design, Synthesis, and Biological Evaluation of Novel 4-Aminopiperidinyl-linked 3,5-Disubstituted-1,.
Chem Biol Drug Des,
86,
107,
2014.
-
[266]
展鹏 and 刘新泳.
The changing face of Hepatitis C: Recent Advances on HCV Inhibitors Targeting NS5A.
Curr Med Chem.,
22,
1860,
2015.
-
[267]
展鹏 , 刘新泳 and 贾海永.
Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent no.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
136,
144,
2017.
-
[268]
刘新泳 , 展鹏 and 张硕.
Efficient drug discovery by rational lead hybridization based on crystallographic overlay.
Drug Discovery Today,
24,
805,
2019.
-
[269]
刘新泳 , 展鹏 and 荆兰兰.
Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inh.
Drug Discovery Today,
24,
629,
2019.
-
[270]
展鹏 , 刘新泳 and 康东伟.
Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors by exploring the structure.
Chemical Biology & Drug Design,
93,
430,
2019.
-
[271]
刘新泳 , 展鹏 and 鞠翰.
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Per.
Journal of Medicinal Chemistry,
60,
3533,
2017.
-
[272]
刘新泳 , 展鹏 and 周忠霞.
Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a.
Organic & Biomolecular Chemistry,
16,
1014,
2018.
-
[273]
展鹏 , 刘新泳 and 高萍.
1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via .
Bioorganic & medicinal chemistry,
25,
5779,
2017.
-
[274]
展鹏 , 刘新泳 and 黄伯世.
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluati.
Expert Opinion on Therapeutic Patents,
27,
9,
2017.
-
[275]
刘新泳 , 展鹏 and 高萍.
Design, synthesis, and biologic evaluation of novel galloyl derivatives as HIV-1 RNase H inhibitors.
Chemical Biology & Drug Design,
93,
582,
2019.
-
[276]
刘新泳 , 展鹏 and 汪昭.
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodru.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
27,
447,
2019.
-
[277]
刘新泳 , 展鹏 and 周忠霞.
Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidi.
Organic and Biomolecular Chemistry,
17,
3202,
2019.
-
[278]
展鹏 , 刘新泳 and 康东伟.
Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Tra.
《Journal of Medicinal Chemistry》,
62,
1484,
2019.
-
[279]
展鹏 , 刘新泳 and 黄伯世.
Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Bindi.
《Journal of Medicinal Chemistry》,
62,
2083,
2019.
-
[280]
展鹏 , 刘新泳 and 汪昭.
Design, synthesis, and antiviral evaluation of novel hydrazone-substituted thiophene[3,2-d]pyrimidin.
Chemical Biology & Drug Design,
92,
2009,
2018.
